IT sleuths raid Cong candidate’s Badami resort after Siddaramaiah spends a night there

Bengaluru, July 17: A 60-year-old woman who tested positive for Covid-19 allegedly ended her life in the Covid ward at KC General Hospital in the early hours of Friday.

The woman, the fourth Covid positive patient to end her life since April, was a resident of Mariyappanapalya near Jnanabharathi in West Bengaluru. She was found hanging from a window grille in the passage of the Covid ward around 5 am. She had used her sari to hang herself.

The police said that the woman was admitted to the hospital on July 1. She was responding well to the treatment and was almost cured. Her son was infected first and admitted to the same hospital. As she later tested positive and got admitted, her son was discharged on July 11. The police suspect that the woman may have resorted to the extreme step due to depression.

An investigating officer quoted doctors telling the police that they were about to inform the woman about her discharge date on Friday. Doctors were waiting for the report on her latest test before discharging her.

The woman’s body will be subjected to an autopsy as per the Covid standard procedure. The Malleswaram police have taken up a case of unnatural death. Investigations are on. 

On July 11, a 70-year-old man ended his life in the toilet of the Covid ward in Victoria Hospital, while a suicide was reported in the same ward on June 26. A 60-year-old woman also hanged herself in the toilet. Her son, daughter-in-law, and grandson were also admitted to hospital for Covid-19.

Bagalkot, April 4: A COVID-19 positive patient passed away in Karnataka's Bagalkot on Friday, taking the total number of deaths in the state to four, informed the Deputy Commissioner of Bagalkot.

The total number of coronavirus cases in the country now stands at 2650 including 184 people who have been discharged or cured or migrated, and 68 deaths, as per the data provided by the Ministry of Health and Family Welfare.

Pune/Bengaluru, Mar 25: e-Zest Solutions and Neurosynaptic Communications today announced the ReMeDi SCAN-CORONA platform, an innovative technology solution to help control the Novel COVID-19 pandemic.
As countries worldwide grapple to contain the spread and flatten the curve while treating the ones infected, the need of the hour is to deploy widespread screening and testing procedures to identify and isolate those showing symptoms.
The ReMeDi® SCAN-CORONA platform has a three-pronged approach to controlling the pandemic that makes the task of screening, testing, tracking and reporting extremely easy and manageable at a large scale.
"Mass screening and testing is the need of the hour. With the scarcity of healthcare professionals, there is a need of technology enabled platforms to do this at a large scale with minimal to no human intervention. The ReMeDi SCAN-CORONA brings together remote healthcare expertise and the power of emerging technology such as AI & ML, and promises to reduce the load on the healthcare system, so that timely care reaches the right set of people as fast as possible," said Shree Shingane - Founder and Managing Director, e-Zest Solutions GmbH.
The solution features a Corona-Screen Kit - a portable, lightweight kit that includes basic screening tools that seamlessly connect and feed data into a Patient Health Record (PHR) system without any manual intervention.
It also features a geo-tagging powered Screening app that, by importing and analyzing data from the screening tools as well as travel and medical history. The input from a third-party COVID-19 rapid testing kit further enhances the accuracy of the outcome.
"ReMeDi SCAN-CORONA helps front-line health workers to quickly assess the essential risk factors for a person digitally. It has the unique ability to track the progression of symptoms with time. The tele-consultation facility allows individuals to obtain counselling as well as consult doctors independent of location, to access timely information and guidance. We are proud to present this solution in collaboration with e-Zest," said Sameer Sawarkar CEO - Neurosynaptic.
The beauty of this solution is that while it can bring a big relief for COVID-19 screening efforts, it is equally advantageous to heavily burdened Healthcare Providers in remotely treating the non-corona health requirements as well.
The team acknowledges the valuable contribution in terms of clinical inputs for application development, from Dr Nandakumar, a renowned public health expert.
"e-Zest vision is to leverage Healthcare technologies to impact human life positively. We are happy to be part of this collaboration & look forward to it's contribution to combat the pandemic challenge globally," said Devendra Deshmukh, e-Zest CEO.
This story is provided by BusinessWire India. ANI will not be responsible in any way for the content of this article.